Judge Raps Cipla For 'Extreme' Suppression Step In Drug Suit
A Federal Court judge has awarded costs against drugmaker Cipla after it tried to suppress information related to its planned generic drug during patent infringement lawsuits brought by U.S. pharmaceutical giant...To view the full article, register now.
Already a subscriber? Click here to view full article